CR6613A - CHANGING THE EXPRESSION OF GENESIS WITH ADSss PRODUCED IN LIVE - Google Patents

CHANGING THE EXPRESSION OF GENESIS WITH ADSss PRODUCED IN LIVE

Info

Publication number
CR6613A
CR6613A CR6613A CR6613A CR6613A CR 6613 A CR6613 A CR 6613A CR 6613 A CR6613 A CR 6613A CR 6613 A CR6613 A CR 6613A CR 6613 A CR6613 A CR 6613A
Authority
CR
Costa Rica
Prior art keywords
expression
adsss
genesis
live
changing
Prior art date
Application number
CR6613A
Other languages
Spanish (es)
Inventor
A Conrad Charles
Chen Yin
Original Assignee
Cytogenix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytogenix Inc filed Critical Cytogenix Inc
Publication of CR6613A publication Critical patent/CR6613A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Un metodo para alterar la expresion de una secuencia de acido nucleico objetivo en una celula objetivo mediante la produccion de ADNc de una sola cadena (ADNC-ss) en la celula objetivo in vivo.A method to alter the expression of a target nucleic acid sequence in a target cell by producing single-stranded cDNA (cDNA-ss) in the target cell in vivo.

CR6613A 1999-10-04 2002-04-03 CHANGING THE EXPRESSION OF GENESIS WITH ADSss PRODUCED IN LIVE CR6613A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41156899A 1999-10-04 1999-10-04
US51470700A 2000-02-28 2000-02-28

Publications (1)

Publication Number Publication Date
CR6613A true CR6613A (en) 2004-04-21

Family

ID=27021437

Family Applications (1)

Application Number Title Priority Date Filing Date
CR6613A CR6613A (en) 1999-10-04 2002-04-03 CHANGING THE EXPRESSION OF GENESIS WITH ADSss PRODUCED IN LIVE

Country Status (11)

Country Link
EP (1) EP1222259A1 (en)
JP (1) JP2003511025A (en)
KR (1) KR20020059608A (en)
CN (1) CN1276083C (en)
AU (1) AU7855300A (en)
BR (1) BR0014814A (en)
CA (1) CA2386246A1 (en)
CR (1) CR6613A (en)
IL (1) IL148946A0 (en)
MX (1) MXPA02003422A (en)
WO (1) WO2001025419A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7419964B2 (en) * 1999-09-16 2008-09-02 Cytogenix, Inc. Treatment of HSV-related pathologies using ssDNA
AU2002230545B2 (en) 2000-10-23 2006-09-21 Gen-Probe Incorporated Compositions and methods for detecting human immunodeficiency virus 2 (HIV-2)
WO2003052071A2 (en) * 2001-12-14 2003-06-26 Yale University Intracellular generation of single-stranded dna
US20050020526A1 (en) * 2003-06-03 2005-01-27 Cytogenix, Inc. Oligodeoxynucleotide intervention for prevention and treatment of sepsis
CN101076589A (en) * 2004-09-28 2007-11-21 西托吉尼克斯公司 Single-stranded antimicrobial oligonucleotides and uses thereof
US8658608B2 (en) 2005-11-23 2014-02-25 Yale University Modified triple-helix forming oligonucleotides for targeted mutagenesis
CN102154269B (en) * 2011-01-06 2012-05-23 湖南农业大学 Polymerase chain reaction (PCR)-based quick construction method for tandem repetitive sequence and special primer pair and use
CN109476706A (en) 2016-02-16 2019-03-15 耶鲁大学 For promoting the composition and its application method of target gene editor
CN108396043A (en) * 2017-02-06 2018-08-14 中国科学院上海应用物理研究所 A kind of preparation method and applications of the ends 5` phosphorylation single stranded DNA
JP7481755B2 (en) * 2018-11-02 2024-05-13 ナイキジェン，リミテッド Recombinant parvovirus vectors and methods for making and using same
GB201913898D0 (en) * 2019-09-26 2019-11-13 Lightbio Ltd Nucleic acid construct

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL142490A0 (en) * 1998-10-09 2002-03-10 Ingene Inc ENZYMATIC SYNTHESIS OF ssDNA
MXPA01003643A (en) * 1998-10-09 2003-07-21 Ingene Inc PRODUCTION OF ssDNA IN VIVO.

Also Published As

Publication number Publication date
CN1399679A (en) 2003-02-26
KR20020059608A (en) 2002-07-13
AU7855300A (en) 2001-05-10
JP2003511025A (en) 2003-03-25
WO2001025419A1 (en) 2001-04-12
CN1276083C (en) 2006-09-20
MXPA02003422A (en) 2004-09-10
IL148946A0 (en) 2002-09-12
EP1222259A1 (en) 2002-07-17
CA2386246A1 (en) 2001-04-12
BR0014814A (en) 2002-09-17

Similar Documents

Publication Publication Date Title
ES2597953T3 (en) Oligoribonucleotide to inhibit the expression of a predetermined gene
AR031480A1 (en) 3-HYDROXIPROPIONIC ACID AND OTHER ORGANIC COMPOUNDS
CR6613A (en) CHANGING THE EXPRESSION OF GENESIS WITH ADSss PRODUCED IN LIVE
CY1106821T1 (en) METHOD FOR CULTIVATING CARTILAGE SUBSTITUTE AND BIOLOGICAL UTERUS PRODUCED ACCORDING TO THE METHOD
AR024318A1 (en) NUCLEIC ACID MOLECULES OF WHEAT, CELLS OF TRANSGENIC PLANTS AND PLANTS AND THE USE OF THE SAME FOR THE MODIFIED ALMIDON PRODUCTION.
SV2005002082A (en) "PROLINA CCI-779, PRODUCTION AND USES OF THE SAME, AND ENZYMATIC SYNTHESIS OF TWO STAGES OF PROLINA CCI-779 AND CCI-779" REF. AM-101578SALVO
AR027600A1 (en) POLYPEPTIDES THAT HAVE ALFA-AMYLASE ALKALINE ACTIVITY AND THE NUCLEIC ACIDS THAT CODE IT
ES2175753T3 (en) BIOSYNTHETIC GRAFT AND METHOD FOR PRODUCTION.
NO20022359L (en) Inhibition of gene expression
ES2061720T3 (en) TRANSFORMATION OF PLANT TISSUE.
AR039716A1 (en) SEQUENCES OF NUCLEIC ACIDS RELATED TO THIOESTERASES AND METHODS OF USE FOR THE PRODUCTION OF PLANTS WITH MODIFIED FATTY ACIDS COMPOSITION
ES2059498T3 (en) PROCEDURE FOR THE PRODUCTION OF AVERMECTIN B AND CROPS FOR IT.
DE60036537D1 (en) COMPOSITIONS FOR GENETHERAPY OF DIABETES
DE60213803D1 (en) Happier mapping
EE03955B1 (en) Use of nucleic acid for the manufacture of a medicament for transfecting at least some cells of the mammalian reproductive tract
BR0212227B1 (en) Fruit thinning agent and processes as well as their employment
ES2157690T3 (en) METHOD OF PRODUCING THE POWER LEVEL RECEIVED IN A BASE STATION OF A CDMA NETWORK AND BASE STATION FOR IMPLEMENTATION.
NO20020949D0 (en) Fatty acid desaturation gene from plants
AR069074A1 (en) MODIFICATION OF LIGNIN BIOSYNTHESIS BY SUPPRESSION WITH NUCLEIC ACID SENSE
CR10319A (en) PRECISE FORMULATIONS DERIVED FROM NODULISPORIC ACID TO COMBAT PARASITES
UA94613C2 (en) Modified enzyme dmo and transgenic plant, producing it
DE602007012100D1 (en) METHOD AND DEVICE FOR COHERENTLY CONNECTING LASER RADIATION
WO2002032211A3 (en) Method of harvesting sugarcane
AR077315A2 (en) PLANTS WITH MODIFIED GROWTH CHARACTERISTICS AND METHOD TO OBTAIN THE SAME
AR014528A1 (en) DNA THAT INCLUDES A SEQUENCE OF NUCLEOTIDES THAT CAN BE TRANSLATED TO A PROTEIN WITH ACTIVITY OF INVERTASE, PROTEIN DERIVED FROM DNA THAT HAS ACTIVITY OF INVERTASE BUT THAT LACKS OF BETA-FRUCTOFURANOSIDASE ACTIVITY; METHOD TO PRODUCE DNA AND SUCH METHOD WHERE DNA IS PRODUCED BY A

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)